AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2016
Nov 16, 2016
31676_dirs_2016-11-16_0029c8bc-8cef-4e83-a7b1-422eb92ac367.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-11-15
Reporting Person: Brown Robert E. JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-15 | Common Stock | M | 3125 | $6.36 | Acquired | 13235 | Direct |
| 2016-11-15 | Common Stock | M | 2333 | $33.00 | Acquired | 15568 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-15 | Option to Purchase | $6.36 | M | 3125 | Disposed | 2023-07-11 | Common Stock (3125) | Direct |
| 2016-11-15 | Option to Purchase | $33.00 | M | 2333 | Disposed | 2024-03-31 | Common Stock (2333) | Direct |
Footnotes
F1: The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3